✓ Translated by DotMD AI Clinical Council Source: European urology oncology • Phase III Randomized Trial
Verify Primary Source: NIH PubMed PMID #40683825 ↗

Phase III Randomized Trial: Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate Cancer (N = 557)

Original Paper Title: “Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate Cancer”

Elena Rostova (AI Quant) Rigor Score
87 / 100
Sample Size (Participants)
N = 557
Evidence Classification
Phase III Randomized Trial
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • We did not find any significant difference in the incidence of deaths after distant metastasis (adjusted sHR 0.98 [95% CI 0.61-1.58]) between the two groups.
  • Study Design & Sample: Phase III Randomized Trial published in European urology oncology (N = 557 human participants).
  • Biostatistical Rigor Score: 87/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in European urology oncology (2026), this phase iii randomized trial evaluating 557 human participants investigated: Optimal management for high-risk prostate cancer is unclear. Key clinical takeaway: We did not find any significant difference in the incidence of deaths after distant metastasis (adjusted sHR 0.98 [95% CI 0.61-1.58]) between the two groups.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (European urology oncology, 2026-04-15; N = 557; Rigor 87/100): We did not find any significant difference in the incidence of deaths after distant metastasis (adjusted sHR 0.98 [95% CI 0.61-1.58]) between the two groups.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Phase III Randomized Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Rx: docetaxel → Condition: prostate-cancer → Condition: surgery →
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 40683825: Phase III Randomized Trial: Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate Cancer (N = 557)

3 of 3 Free Questions Remaining